These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3003493)

  • 21. Mapping of type 1 poliovirus neutralization epitopes.
    Blondel B; Crainic R; Dufraisse G; Candréa A; Horaud F
    Dev Biol Stand; 1985; 60():337-42. PubMed ID: 2412917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular Characterization of Polio from Environmental Samples: ISSP, The Israeli Sewage Surveillance Protocol.
    Shulman LM; Manor Y; Hindiyeh M; Sofer D; Mendelson E
    Methods Mol Biol; 2016; 1387():55-107. PubMed ID: 26983731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of antigenic properties of vaccine derived poliovirus strains.
    Pliaka V; Achilleos C; Kyriakopoulou Z; Tsakogiannis D; Ruether IG; Gartzonica C; Levidiotou-Stefanou S; Markoulatos P
    Vaccine; 2010 Dec; 29(1):26-33. PubMed ID: 20974307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Intratypical antigenic differentiation of poliovirus strains circulating in Mali by means of cross-adsorbed sera].
    Pervikov IuV; Fafana Ia; Koldoba LG
    Vopr Virusol; 1978; (4):470-3. PubMed ID: 86237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigenic conservation and divergence between the viral-specific proteins of poliovirus type 1 and various picornaviruses.
    Emini EA; Schleif WA; Colonno RJ; Wimmer E
    Virology; 1985 Jan; 140(1):13-20. PubMed ID: 2981447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antigenic hybrids of poliovirus.
    Hogle JM
    Nature; 1988 Mar; 332(6159):13-4. PubMed ID: 2831454
    [No Abstract]   [Full Text] [Related]  

  • 27. Isolation and Characterization of Vaccine-Derived Polioviruses, Relevance for the Global Polio Eradication Initiative.
    Xu W; Zhang Y
    Methods Mol Biol; 2016; 1387():213-26. PubMed ID: 26983736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunochemical studies of polioviruses: identification of immunoreactive virus capsid polypeptides.
    Thorpe R; Minor PD; Mackay A; Schild GC; Spitz M
    J Gen Virol; 1982 Dec; 63(2):487-92. PubMed ID: 6185628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antigen differences of genetic variants Abent+ and Abent- poliovirus vaccine strain of III type].
    Shyrobokov VP; Kostenko IH; Nikolaienko IV
    Mikrobiol Z; 2003; 65(4):29-36. PubMed ID: 14618784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation of vaccine-derived type 1 polioviruses displaying similar properties to virulent wild strain Mahoney from sewage in Japan.
    Horie H; Yoshida H; Matsuura K; Miyazawa M; Wakabayashi K; Nomoto A; Hashizume S
    J Med Virol; 2002 Nov; 68(3):445-51. PubMed ID: 12226835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ANTIGENIC DIFFERENTIATION OF POLIOVIRUSES BY ABSORBED HYPERIMMUNE SERA. I. ANTIGENIC DIFFERENTIATION OF TYPE I STRAINS OF DIVERSE ORIGIN.
    EYLAN E; FOGEL A; DUKLER R; RANNON L
    J Immunol; 1965 Jul; 95():171-80. PubMed ID: 14328695
    [No Abstract]   [Full Text] [Related]  

  • 32. Sabin Vaccine Reversion in the Field: a Comprehensive Analysis of Sabin-Like Poliovirus Isolates in Nigeria.
    Famulare M; Chang S; Iber J; Zhao K; Adeniji JA; Bukbuk D; Baba M; Behrend M; Burns CC; Oberste MS
    J Virol; 2016 Jan; 90(1):317-31. PubMed ID: 26468545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improvement of methods for intratypic differentiation of polioviruses. I. Agar gel diffusion precipitation test with repeated addition of antigens for differentiation between wild and vaccine polioviruses type 1 and 2.
    Chumakov MP; Rubin SG; Balayan MS; Savinskaya SS; Voroshilova MK; Zhevandrova VI; Shekoyan LA; Kazantseva VA
    Arch Gesamte Virusforsch; 1974; 46(1-2):61-5. PubMed ID: 4374167
    [No Abstract]   [Full Text] [Related]  

  • 34. [Variability of poliomyelitis virus strains in nature and significance of this factor for the prevention of poliomyelitis].
    Gendon IuZ
    Vopr Virusol; 1988; 33(2):137-41. PubMed ID: 2457986
    [No Abstract]   [Full Text] [Related]  

  • 35. Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3.
    Minor PD; Evans DM; Ferguson M; Schild GC; Westrop G; Almond JW
    J Gen Virol; 1985 May; 66 ( Pt 5)():1159-65. PubMed ID: 2582084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigenic structure of poliovirus in inactivated vaccines.
    Ferguson M; Wood DJ; Minor PD
    J Gen Virol; 1993 Apr; 74 ( Pt 4)():685-90. PubMed ID: 7682250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoassay of poliovirus antigens by single-radial-diffusion: development and characteristics of a sensitive autoradiographic zone size enhancement (ZE) technique.
    Schild GC; Wood JM; Minor PD; Dandawate CN; Magrath DI
    J Gen Virol; 1980 Nov; 51(Pt 1):157-70. PubMed ID: 6161997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poliovirus strain characterization: a WHO memorandum.
    Bull World Health Organ; 1980; 58(5):727-30. PubMed ID: 6170471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differentiation of poliovirus type I isolates in the 1982 epidemic from Sabin-I strain by antigenic and temperature markers.
    Lee CN; Kao CL; Lee CY
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Feb; 20(1):80-8. PubMed ID: 3036431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Monoclonal antibodies used to differentiate between poliovirus types 1 and 3].
    Shirobokov VP; Kopanitsa LV; Nikolaenko IV; Lipatnikova KI; Sologub VK
    Mikrobiol Z; 2001; 63(6):42-52. PubMed ID: 11944335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.